Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 5.07 · 8-K

OSR Health, Inc.

Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders On August 7, 2026, the Company held an annual meeting of its stockholders (the “ Annual Meeting ”). As of the close of business on July 8, 2026, the record date for the Annual Meeting, there were 35,118,692 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), issued and outstanding, each of which was en…

Filed Aug 10, 2026Accepted Aug 10, 2026, 11:09 AM EDTCIK 1840425Accession 0001213900-26-087087
Share

Company context

OSR Health, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.osr-health.com

Current securities

Historical securities (5)

Recent company filings

  1. Other EventsAug 28, 2026
  2. Other EventsAug 25, 2026
  3. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureAug 19, 2026
  4. SCHEDULE 13G/A filingAug 17, 2026
  5. 10-Q filingAug 14, 2026

Disclosure sections

Items 5.07

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07. Submission of Matters to a Vote of Security Holders On August 7, 2026, the Company held an annual meeting of its stockholders (the “ Annual Meeting ”). As of the close of business on July 8, 2026, the record date for the Annual Meeting, there were 35,118,692 shares of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), issued and outstanding, each of which was entitled to one vote with respect to each of the proposals presented at the Annual Meeting. A total of 21,088,120 shares of Common Stock, representing approximately 60.05% of the outstanding shares of Common Stock entitled to vote at the Annual Meeting, were present in person or by proxy, constituting a quorum. The proposals listed below are described in more detail in the Definitive Proxy Statement on Form DEF 14A filed by the Company with the SEC on July 16, 2026 (the “ Proxy Statement ”). Director Proposal At the Annual Meeting, stockholders re-elected seven (7) directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified. The final voting results were as follows: FOR WITHHELD RESULT ────────────────────────────────────────────────────────────── Kuk Hyoun Hwang 15,174,735 129,046 Elected Jun Chul Whang 15,175,735 128,046 Elected Alcide Barberis 15,185,385 118,396 Elected Seng Chin Mah 15,170,280 133,501 Elected Hyuk Joo Jee 15,174,735 129,046 Elected Joong Myung Cho 15,170,315 133,466 Elected Reto Fierz 15,179,965 123,816 Elected Ratification of Independent Auditor Proposal The stockholders approved the Ratification of Independent Auditor Proposal by the votes set forth in the table below: FOR AGAINST ABSTAIN ──────────────────────────────────────── 20,296,535 201,444 590,141 Executive Compensation Proposal The stockholders approved the Executive Compensation Proposal by the votes set forth in the table below: FOR AGAINST ABSTAIN ──────────────────────────────────────── 15,059,135 83,113 161,533 Authorized Shares Increase Proposal The stockholders approved the Authorized Shares Increase Proposal by the votes set forth in the table below: FOR AGAINST ABSTAIN ──────────────────────────────────────── 19,922,498 581,009 584,613